Abstract
A new series of bisindole based sulfonates (4a-t) have been synthesized and evaluated for their anticancer activity against various human cancer cell lines. Some of these compounds exhibited good inhibitory activity against most of the cell lines tested. Interestingly all the compounds from the bisindole sulfonate series exhibited selective inhibition against MCF-7 cell line. Further these compounds have also been tested for their inhibition of tubulin polymerization. The compounds 4a, 4l, 4n, 4r and 4t demonstrated a dose dependent tubulin inhibition with IC50 values of 2.3, 1.7, 8.1, 6.0 and 10 μM, respectively. Thus, results have demonstrated that antiproliferative activity of these compounds is related to their inhibition of tubulin polymerization.
Keywords: Anticancer activity, Indoles, Sulfonates, Tubulin polymerization, Bisindole Sulfonates, cyclin-dependent kinases (CDKs), antiangiogenic, heterocyclic ring system, indole, mitomycin, cytotoxicity, Micro mass, Column chromatography
Letters in Drug Design & Discovery
Title: Synthesis, Anticancer Activity and Inhibition of Tubulin Polymerization of Bisindole Sulfonates
Volume: 9 Issue: 3
Author(s): Ahmed Kamal, Y. V.V. Srikanth, M. Naseer Ahmed Khan, Md. Ashraf, Thokhir Basha Shaik and Shasi V. Kalivendi
Affiliation:
Keywords: Anticancer activity, Indoles, Sulfonates, Tubulin polymerization, Bisindole Sulfonates, cyclin-dependent kinases (CDKs), antiangiogenic, heterocyclic ring system, indole, mitomycin, cytotoxicity, Micro mass, Column chromatography
Abstract: A new series of bisindole based sulfonates (4a-t) have been synthesized and evaluated for their anticancer activity against various human cancer cell lines. Some of these compounds exhibited good inhibitory activity against most of the cell lines tested. Interestingly all the compounds from the bisindole sulfonate series exhibited selective inhibition against MCF-7 cell line. Further these compounds have also been tested for their inhibition of tubulin polymerization. The compounds 4a, 4l, 4n, 4r and 4t demonstrated a dose dependent tubulin inhibition with IC50 values of 2.3, 1.7, 8.1, 6.0 and 10 μM, respectively. Thus, results have demonstrated that antiproliferative activity of these compounds is related to their inhibition of tubulin polymerization.
Export Options
About this article
Cite this article as:
Kamal Ahmed, V.V. Srikanth Y., Naseer Ahmed Khan M., Ashraf Md., Basha Shaik Thokhir and V. Kalivendi Shasi, Synthesis, Anticancer Activity and Inhibition of Tubulin Polymerization of Bisindole Sulfonates, Letters in Drug Design & Discovery 2012; 9 (3) . https://dx.doi.org/10.2174/157018012799129774
DOI https://dx.doi.org/10.2174/157018012799129774 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Tissue-Based Approaches to Study Pharmacodynamic Endpoints in Early Phase Oncology Clinical Trials
Current Drug Targets Molecules to Selectively Target Receptors for Treatment of Pain and Neurogenic Inflammation
Recent Patents on Inflammation & Allergy Drug Discovery Structural and Modeling Studies on ecto-5’-nucleotidase Aiding in Inhibitor Design
Mini-Reviews in Medicinal Chemistry Snake Venom Metalloproteinases: Structure, Mechanism and Induced Diseases
Current Chemical Biology Design, Synthesis and Antiproliferative Activity of 2-Acetamidothiazole-5- carboxamide Derivatives
Medicinal Chemistry Anti-Angiogenic Effects of Resveratrol on Cerebral Angiogenesis
Current Neurovascular Research Recent Development and Application of Magnetic Nanoparticles for Cell Labeling and Imaging
Mini-Reviews in Medicinal Chemistry Postoperative Radiotherapy After Radical Prostatectomy: Adjuvant or Salvage?
Current Cancer Therapy Reviews Immune Modulation by Plasmid DNA-mediated Cytokine Gene Transfer
Current Pharmaceutical Design Lone Atrial Fibrillation- A Diagnosis of Exclusion
Current Pharmaceutical Design Comparison of Triflusal with Aspirin in the Secondary Prevention of Atherothrombotic Events; Α Randomised Clinical Trial
Current Vascular Pharmacology A Perspective on 10-Years HTS Experience at the Walter and Eliza Hall Institute of Medical Research – Eighteen Million Assays and Counting
Combinatorial Chemistry & High Throughput Screening The Molecular Basis of Class Side Effects Due to Treatment with Inhibitors of the VEGF/VEGFR Pathway
Current Clinical Pharmacology Breast Cancer: Understanding Sensitivity and Resistance to Chemotherapy and Targeted Therapies to Aid in Personalised Medicine
Current Cancer Drug Targets Many Drugs and Phytochemicals Can Be Activated to Biological Reactive Intermediates
Current Drug Metabolism Synergistic Two-Way Interactions of Dietary Polyphenols and Dietary Components on the Gut Microbial Composition: Is There a Positive, Negative, or Neutralizing Effect in the Prevention and Management of Metabolic Diseases?
Current Protein & Peptide Science Recent Development in [1,4]Benzodiazepines as Potent Anticancer Agents: A Review
Mini-Reviews in Medicinal Chemistry Multidrug Resistance ABC Transporter Structure Predictions by Homology Modeling Approaches
Current Drug Metabolism Human Multidrug Transporter ABCG2, a Target for Sensitizing Drug Resistance in Cancer Chemotherapy
Current Medicinal Chemistry NHE-1: A Promising Target for Novel Anti-cancer Therapeutics
Current Pharmaceutical Design